AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2017 Issue 4; New/Revised ICD-10-PCS Procedure Codes
New Therapeutic Substances
Four new Substance values were added to code table XW0, Anatomical Regions, Introduction, as follows: Device/Substance/TechnologyA Bezlotoxumab Monoclonal Antibody B Cytarine and Daunorubicin Liposome Antineoplastic C Engineered Autologous Chimeric Antigen Receptor T-Cell Immunotherapy F Other New Technology Therapeutic Substance Bezlotoxumab Bezlotoxumab, also known by its brand name ZINPLAVA, is used to treat patients who are already receiving an antibiotic for Clostridium difficile infection but who are at high risk for recurrence. Rather than targeting the Clostridium difficile bacteria itself as the antibiotic does, Bezlotoxumab is a monoclonal antibody that targets toxins produced by the Clostridium difficile bacteria, and...
To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com